Veru Inc.

US$2.12As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:VERUHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (13.90%)
Div yield —
ROE (64.54%)
Biotechnology
Beta (5Y) (1.20)
PE TTM —
TSR TTM (28.14%)
Mkt cap US$36.15M
ROIC (453.18%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.34
10.30%
(83.16%)
Hold 0|7|11|1|9
1Q26
2Q26
3Q26
4Q26
Earnings per share$
0.03
0.03
0.03
0.03
32.30%
19.98%
21.83%
33.63%
Revenue$M
1.647
1.661
1.645
1.730
0.93%
4.31%
3.92%
10.06%
Peers (US$36.15M)
Cap (US$)
PE
35.03M
61.89x
Capital
TTM
5Y
10Y
Leveragex
1.481
0.617
0.579
EBIT/Intx
2.647
0.485
0.408
Own earn%
(17.37)
(98.40)
(88.80)
Sh yield%
47.00
22.22
18.60
Owners
Insiders/Inst%
2.94
49.90
Short interest%
4.20
SBC / revenue%
0.79
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
8–16
$1 testx
—
Incr. ROIC%
6